These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

891 related items for PubMed ID: 19520717

  • 1. Update on the treatment of Pseudomonas aeruginosa pneumonia.
    El Solh AA, Alhajhusain A.
    J Antimicrob Chemother; 2009 Aug; 64(2):229-38. PubMed ID: 19520717
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
    Bhat S, Fujitani S, Potoski BA, Capitano B, Linden PK, Shutt K, Paterson DL.
    Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa.
    Rice LB.
    Clin Infect Dis; 2006 Sep 01; 43 Suppl 2():S100-5. PubMed ID: 16894511
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of the onset and consequences of pneumonia due to fluoroquinolone-susceptible or -resistant Pseudomonas aeruginosa.
    Paladino JA, Sunderlin JL, Forrest A, Schentag JJ.
    J Antimicrob Chemother; 2003 Sep 01; 52(3):457-63. PubMed ID: 12888598
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Hospital infections caused by Pseudomonas aeruginosa. Significance in intensive therapy].
    Sidorenko SV, Gel'fand EB, Mamontova OA.
    Anesteziol Reanimatol; 1999 Sep 01; (3):46-54. PubMed ID: 10458038
    [Abstract] [Full Text] [Related]

  • 12. Risk of developing pneumonia is enhanced by the combined traits of fluoroquinolone resistance and type III secretion virulence in respiratory isolates of Pseudomonas aeruginosa.
    Sullivan E, Bensman J, Lou M, Agnello M, Shriner K, Wong-Beringer A.
    Crit Care Med; 2014 Jan 01; 42(1):48-56. PubMed ID: 23963124
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of antibiotic-resistant bacteria on the outcome of ventilator-associated pneumonia.
    Combes A, Luyt CE, Trouillet JL.
    Semin Respir Crit Care Med; 2006 Feb 01; 27(1):23-8. PubMed ID: 16508878
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.